Home

James A. Jr. Robinson

CIK 1734295 · PEO;CEO/Urovant Sciences, Inc. · last filed 2026-06-24

James A. Jr. Robinson is a PEO;CEO/Urovant Sciences, Inc. who has filed 27 SEC Form 4 insider transactions across 6 companies since 2018. The most recent filing, for URGN, was dated Jun 24, 2026. Current disclosed insider exposure totals $572.6K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$572.6K

Companies

6

Total Filings

27

Lifetime Open-Market Net

$0

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
URGN Director 6,000 $40.88 $245.3K $0 9 2026-06-24
ELDN Director 3,430 $3.40 $11.7K $0 3 2026-01-16
APPLIED GENETIC TECHNOLOGIES CORP (AGTC) Delisted Director — $0.39 — $0 2 2022-12-01
Neos Therapeutics, Inc. (NEOS) Delisted Director 0 $1.15 $0 $0 4 2021-03-19
Urovant Sciences Ltd. (UROV) Delisted PEO; CEO/Urovant Sciences, Inc 8,385 $16.24 $136.2K $0 5 2021-01-12
ALKS President & COO,Alkermes, Inc. 6,250 $50.50 $315.6K $0 3 2019-04-05

Recent Filings

27 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-06-24 URGN Grant (A) — $0 EDGAR
2026-05-27 URGN Exer (M) +2,000 $0 EDGAR
2026-02-27 URGN Exer (M) +2,000 $0 EDGAR
2026-01-16 ELDN Exer (M) +3,430 $0 EDGAR
2025-12-01 URGN Exer (M) +2,000 $0 EDGAR
2025-08-27 URGN Grant (A) — $0 EDGAR
2025-01-13 ELDN Grant (A) — $0 EDGAR
2024-08-08 URGN Grant (A) — $0 EDGAR
2023-10-03 ELDN Grant (A) — $0 EDGAR
2023-09-08 URGN Grant (A) — $0 EDGAR
Showing 1–10 of 27
Page 1 of 3
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.